TCL Archive Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials March 26, 2004
TCL Archive In Brief: Flood Gives Up Chairmanship, Which Goes to Natcher; Kennedy Hearings Feb. 22-23 February 2, 1979
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive FDA news: Von Eschenbach to FDA staff: “I did not come here to be a figurehead…. While I am here, I will lead.” November 4, 2005
